Differential Treatment Effects of Subgroup Analyses in Oncology Trials, 2004-2020
This cross-sectional study evaluates the credibility of differential treatment effect claims in published phase 3 randomized clinical oncology trials published prior to 2021 according to the Instrument for Assessing the Credibility of Effect Modification Analyses.